You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Stable Glucagon for Treatment of Hyperinsulinism
SBC: AMIDEBIO, LLC Topic: 200In severe persistent hyperinsulinism (HI), repeated hypoglycemic episodes can ultimately lead to permanent seizure disorders, learning disabilities, cerebral palsy, blindness and even death. Clinical studies have demonstrated the effectiveness of both short-term and long-term treatment with glucagon for severe forms of HI and continuous subcutaneous administration of glucagon has been recommended ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
Development of Serious Games and Physical Activities Instructed by a Social Robot for Improving the Well-being of Elderly Individuals with Alzheimer's Disease and Dementia
SBC: Dream Face Technologies, LLC Topic: NIAThe objective of the proposed direct Phase-II SBIR project is to develop and study and the effectiveness of Serious Games and physical Activities played/performed by elderly people with Alzheimer’s disease and AD- related Dementias in interaction with Ryan, our successfully piloted Socially Assistive Robot (SAR). Ryan is an intelligent conversational life-like social robot, designed to improve t ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
A Quality Control Program for Quantitative MRI DataAcquisition and Analysis in Multi-site Clinical Trials
SBC: CALIBERMRI INC Topic: 101Project Summary/Abstract There has been a shift to greater use of neadjuvant chemotherapy (NACT) in the clinical management of cancer. Often used in breast cancer to provide systemic treatment for possible or apparent metastatic disease, NACT also reduces the primary tumor size and facilitates breast conservation. Quantitative magnetic resonance imaging (qMRI) is an effective diagnostic for monito ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
Developing a peptide-based oral drug to prevent kidney stones
SBC: Oxalo Therapeutics, Inc. Topic: 400Project Summary/Abstract Kidney stones (KS) are highly prevalent, excruciating, and associated with long term complications of chronic kidney disease (CKD) and end stage renal disease (ESRD). They account for 1.3M ER visits and andgt;$10B of medical costs annually and have a striking recurrence rate of 50% in 5 years and up to 80% in 10 years, reflecting the inadequacies of current interventions. ...
STTR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
First and Only Soft Tissue Support Device to Improve Patient Experience and System Cost in Breast Reconstruction
SBC: Surgical Innovation Associates, Inc. Topic: 102NOTE: These pages contain proprietary/privileged information. SIA requests that they not be released to personsoutside the Government, except for purposes of review and evaluation. Project Summary/Abstract DuraSorb™ is poised to significantly improve the lives of the over 100,000 US women undergoing post- mastectomy breast reconstruction every year. The current standard of care in implant-based ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
C.A.R.E.S.: A Mobile Health Program for Alcohol Risk Reduction for an Under-Served College Population
SBC: LIVE INSPIRED LLC Topic: 550Excessive alcohol use is the third-leading preventable cause of death in the U.S. with young adults ages 18-29 showing the highest rates of hazardous alcohol use. Community colleges serve over 12 million students, comprising 45% of all U.S. college students. Community college students (CCS) show rates of heavy alcohol use similar to students at traditional four-year residential (FYR) colleges, but ...
STTR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
Single-cell Phosphoprotein Assay to Evaluate Brain Tumor Therapeutic Resistance
SBC: ISOPLEXIS CORPORATION Topic: 102Although signal transduction inhibitors occasionally offer clinical benefit for cancer patients, signal flux emanating from oncogenes is often distributed through multiple pathways, potentially underlying the resistance which causes failure of most such inhibitors. Measuring signal flux through multiple pathways, in response to signal transduction inhibitors, may help uncover network inter- action ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
Development of Ryan Companion Robot for Assisting Elderly People with Alzheimer's Disease
SBC: Dream Face Technologies, LLC Topic: NIAThe objective of the proposed Fast-Track SBIR effort is to develop and commercialize the Ryan CompanionBot (hereafter, Ryan), an intelligent conversational life-like social robot, designed to improve the well-being and quality of life of older adults with early stage Alzheimerandapos;s disease (AD) and AD-Related Dementia (ADRD). According to the NIA, research reports estimate that as many as 5.1 ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
A wearable sensor system for hand hygiene compliance tracking
SBC: Microsensor Labs, LLC Topic: RProject Summary This Small Business Innovation Research Fast Track project aims to develop a wearable sensor system for hand hygiene compliance tracking and validate its efficacy through a pilot trial in clinical settings. Healthcare- Associated Infections (HAIs) are the most common type of complication for patients who are hospitalized. According to the Center for Disease Control and Prevention, ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
4-(Aminomethyl) benzamides as novel anti-Ebola agents
SBC: Chicago Biosolutions, Inc. Topic: NIAIDEbola (EBOV) and Marburg (MARV) viruses belong to the Filoviridae family and can cause fatal hemorrhagic fevers characterized by widespread tissue destruction after an incubation period of 4-14 days. Due to safety concerns, these viruses are designated as biosafety level 4 agents. Currently, there is no effective vaccine or therapeutic treatment for filoviral infections in humans. Africa has recen ...
STTR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health